Exploring Potential Multi‐Target Inhibition Mechanisms of Ganoderma lucidum Against EBV‐Mediated DLBCL Using Integrative Bioinformatics, Machine Learning, and Network Pharmacology Approaches

药物数据库 药理学 计算生物学 化学 AKT1型 灵芝 异鼠李素 小RNA 广告 山奈酚 转录组 IC50型 系统药理学 生物 癌症研究 高良姜素 生物信息学 小桶 生物信息学 结合位点 结合亲和力
作者
Azrin Ahmed,Md. Abdul Kader,Sheikh Abdullah Al Ashik
出处
期刊:Journal of Food Science [Wiley]
卷期号:91 (10): e71575-e71575
标识
DOI:10.1111/1750-3841.71575
摘要

ABSTRACT Epstein–Barr virus (EBV)‐associated diffuse large B‐cell lymphoma (DLBCL) represents a significant clinical challenge with limited targeted therapeutic options. Despite the known antiviral and anticancer properties of Ganoderma lucidum , its specific molecular mechanisms against EBV‐mediated DLBCL remain unexplored. Therefore, this study aimed to investigate the potential multi‐target inhibitory mechanisms of G. lucidum compounds against EBV‐associated DLBCL by integrating absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling of 1046 compounds; network pharmacology analysis for target identification; transcriptomic evaluation using DLBCL patient datasets from The Cancer Genome Atlas (TCGA) and Genotype‐Tissue Expression (GTEx) ( n = 47 tumors, n = 337 normals); molecular docking; density functional theory (DFT) calculations; machine learning–based activity prediction, molecular dynamics (MD) simulations; and Molecular Mechanics Poisson–Boltzmann Surface Area (MM–PBSA) binding free energy calculations. Eight compounds (kobusin, chrysin, dalbergin, galangin, isorhamnetin, lauric acid, piperbetol, and vitamin D3) demonstrated favorable ADMET profiles. Network pharmacology analysis identified 217 common targets, with AKT1 and BCL2 significantly upregulated in DLBCL tumors. Isorhamnetin showed the strongest AKT1 binding (−8.33 kcal/mol), surpassing control (−5.11 kcal/mol), whereas galangin exhibited the highest BCL2 affinity (−6.13 kcal/mol), outperforming control (−5.23 kcal/mol). Random forest achieved cross‐validation scores of 0.8634 ± 0.0158 for AKT1 and 0.8965 ± 0.0146 for BCL2, predicting IC 50 <1000 nM for all compounds. MD simulations confirmed the binding stability of all compounds with low root mean square deviation (RMSD, <2.5 Å). MM–PBSA calculations revealed favorable binding free energies of −23.01 kcal/mol (AKT1‐galangin), −19.01 kcal/mol (AKT1‐isorhamnetin), −32.15 kcal/mol (BCL2‐isorhamnetin), and −28.97 kcal/mol (BCL2‐galangin). Therefore, isorhamnetin and galangin may have multi‐target inhibitory potential against AKT1 and BCL2, providing a robust foundation for further in vitro and in vivo validation as therapeutic candidates for EBV‐mediated DLBCL intervention. Practical Applications Ganoderma lucidum is a medicinal mushroom widely used in traditional and functional food applications and may serve as a source of natural anticancer compounds with potential benefits for EBV‐associated diffuse large B‐cell lymphoma. The multi‐targeting potential of G. lucidum –derived bioactive constituents, isorhamnetin and galangin, against AKT1 and BCL2 may position it as a promising functional food‐based candidate for anticancer therapeutics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
maguodrgon发布了新的文献求助10
刚刚
吃葡萄不吐葡萄皮的应助被zyy采纳,获得30
刚刚
晓晓完成签到,获得积分10
刚刚
LYK2997499077完成签到,获得积分10
1秒前
yy发布了新的文献求助10
1秒前
2秒前
受伤白安发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
无名发布了新的文献求助10
3秒前
谷音发布了新的文献求助10
3秒前
小陈完成签到,获得积分10
4秒前
拂晓完成签到,获得积分10
4秒前
4秒前
一勺白桃完成签到 ,获得积分10
4秒前
研友_VZG7GZ的应助被didida采纳,获得10
5秒前
默默白桃发布了新的文献求助10
5秒前
5秒前
奇崽完成签到,获得积分10
5秒前
搜集达人的应助被yy采纳,获得10
6秒前
6秒前
6秒前
6秒前
旻洛完成签到 ,获得积分10
6秒前
零的孤心俱乐部完成签到,获得积分10
7秒前
魔修完成签到,获得积分10
7秒前
人生海海完成签到,获得积分20
7秒前
8秒前
小青完成签到 ,获得积分10
8秒前
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182102
求助须知:如何正确求助?哪些是违规求助? 9571775
关于积分的说明 21819723
捐赠科研通 7778500
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479651